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Acridines were first developed as dyes, and since the early 20th century their varied
properties have continued to be of interested. Derivatives of acridine showed good cyto-
toxic activity against human leukemia cells. They are found to be potent drugs towards
metastatic breast cancer cells.1–2 Acridine can be used in chemosensors,3 dyes,4 fluores-
cent probes,5–6 anticonvulsant,7 analgesic,8 hypertensive,9 and anti-inflammatory medi-
cations10 and in chiral optical materials.11 Proflavin has been used as an antibacterial
and antifungal agent.12 Acridines such as quinacrine, pyronaridine and acranil have
been used as antimalarial drugs.13 Acridines have been utilized as single agents or in
combination with other antineoplastic drugs in the treatment of acute non-lymphocytic
and lymphocytic leukemia,14,15 and against lung cancer.16 Acridines inhibit RNA
synthesis.17
Several catalysts have been used for the synthesis of N-substituted 3,3,6,6-tetra-
methyl-9,10-diphenyl-3,4,6,7,9,10-hexahydroacridine-1,8-(2H,5H)-dione derivatives (4);
these include [2-MPyH]OTf,18 SBA Pr-SO3H,
19 DABCO-PEG ionic liquid,20 SiO2/
ZnCl2,
21 Cu doped nano ZnO,22 SiO2I,
23 silica bonded N-propyl sulfamic acid,24
BNBTS,25 K2CO3 and Cu2Cl2.
26 Some of the reported synthetic protocols used expen-
sive reagents, extended reaction times, high reaction temperatures or lengthy work-up
procedures. In the present work we describe a fast and green approach for the synthesis
of compounds (4) by using camphor sulfonic acid (CSA) (Scheme 1).
In search of the best experimental reaction conditions, the reaction of dimedone 1,
benzaldehyde 2 and aniline 3 was considered as a model reaction (Scheme 1). The reac-
tion was carried out using CSA and other catalysts as reported in the literature (Table
1). The reaction went smoothly and in high yield by using CSA in ethanol (Table 1,
entry 6). When the reaction was carried out in the absence of catalyst, the product
formed in only a trace amount (Table 2, entry 1). To optimize the concentration of
CSA required to obtain high yields of product in the model reaction, we investigated 2,
4, 6, 8, 10, 12 and 14mol % catalyst (Table 2). Optimal results were obtained with
Received August 14, 2017; in final form August 10, 2018.
Address correspondence to R. P. Pawar, Department of Chemistry, Deogiri College, Station
Road, Aurangabad, 431 005, MS, India. E-mail: rppawar@yahoo.com
1
Organic Preparations and Procedures International, 0:1–6, 2019
# 2019 Taylor & Francis Group, LLC
ISSN: 0030-4948 print / 1945-5453 online
DOI: 10.1080/00304948.2018.1549907
10 mol % of catalyst (Table 2, entry 6). In order to evaluate the effect of solvent, reac-
tions were carried out as listed in Table 3. Toluene, acetonitrile, DMF and DCM
afforded moderate yields. Methanol and DMSO resulted in good yields; but ethanol fur-
nished the product in 90% yield (Table 3, entry 6), making it the most favorable solv-
ent. To explore the scope of the method, different aldehydes and anilines were treated
with dimedone in the presence of 10mol % of CSA using ethanol as a solvent. All the
Scheme 1. Standard model reaction.
Table 1
Effect of Catalyst and Solvents
Entries Catalysts Solvent Time (h/ min) Temp. (C) Yield (%) Ref.
1 SBA-Pr-SO3H – 5min 140 69 19
2 SiO2-I Ethanol 2–5 h 80 40–90 23
3 TEBAC Water 10–12 h 100 90 28
4 NH2SO3H Ethanol 2 h 140 60–75 24
5 BNBTS – 0.5–2 h 90 80 25
6 CSA Ethanol 30min 60 90–94 Present work
Table 2
Effect of Concentration of Catalyst
Entries Mol % Solvent Time (min) Temp (C) Yield (%)
1 No catalyst Ethanol 30 Reflux Trace
2 2 Ethanol 30 Reflux 30
3 4 Ethanol 30 Reflux 50
4 6 Ethanol 30 Reflux 60
5 8 Ethanol 30 Reflux 80
6 10 Ethanol 30 Reflux 90
7 12 Ethanol 30 Reflux 90
8 14 Ethanol 30 Reflux 90
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substrates were well tolerated under the optimized conditions, furnishing the product in
uniformly high yields. The results are compiled in Table 4. Formation of the desired
product was confirmed by comparing the melting points with the literature values and
by IR, 1H NMR, 13C NMR and mass spectroscopic data.
In summary, we have developed a practical approach for the synthesis of compounds
4 via the multicomponent reaction of substituted amines, aldehydes and dimedone using
CSA catalyst in ethanol. This procedure is rapid and greener than some of the previous
methods, in that it avoids the use of more toxic solvents and requires less heating.
Experimental Section
Chemicals were purchased from SD Fine or Sigma Aldrich and used without further
purification. Melting points of the products were recorded on a digital melting point
Table 3
Screening of Solvent
Entries Solvent CSA mol % Time (min) Temp (C) Yield (%)
1 Toluene 10 30 Reflux 60
2 Acetonitrile 10 30 Reflux 70
3 DMF 10 30 Reflux 75
4 DCM 10 30 Reflux 70
5 Methanol 10 30 Reflux 80
6 Ethanol 10 30 Reflux 90
7 DMSO 10 30 Reflux 78
Table 4
Synthesis of Acridine Derivatives
Entry Aldehyde (R1) Amine (R2) Time (Min.) Yield (%)
MP (oC)
Ref. No.Observed Reported
4a 4-Cl 4-Cl 30 90 303–305 303–305 18
4b 4-Cl 4-Me 30 91 273–275 273–275 18, 27
4c 4-Cl 4-Me 30 92 242–245 243–245 27
4d 4-NO2 -H 30 90 278–280 281–282 27
4e 4-OH 4-Me 30 91 284–287 347–349 18
4f 3-NO2 4-Me 30 90 280–284 279–282 27
4g 4-Me 4-Me 30 93 296–298 295–297 18
4h 4-OH, 3-OMe 4-Me 30 92 272–274 273–275 18
4i 4-OMe 3-NO2 30 90 275–277 276–278 19
4j 4-NO2 -H 30 90 278–280 278–280 26
4k 3-NO2 -H 30 93 276–278 277–279 18
4l 4-OMe -H 30 93 217–219 222–224 18
4m -H -H 30 90 252–254 255–257 18
Reaction conditions: Dimedone (2mmol), aromatic amine (1mmol), aldehyde derivatives
(1mmol), CSA catalyst (10mol %), ethanol solvent (2mL).
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apparatus (Optics Technology). The reactions were monitored using thin layer chroma-
tography (TLC) in 40% ethyl acetate:n-hexane on silica gel precoated aluminum foil
(Merck). FT-IR (KBr) spectra were recorded at room temperature on a Varian Inova
spectrometer, and 1H NMR spectra in CDCl3 using tetramethylsilane (TMS) as internal
standard on a Brucker Vector spectrometer.
General Procedure for the Synthesis of 3,3,6,6-Tetramethyl-9,10-diphenyl-
3,4,6,7,9,10-hexahydroacridine-1,8-(2H,5H)-diones (4)
In a round bottom flask were placed cyclohexanedione 1 (2mmol), an aromatic alde-
hyde 2 (1mmol), an aniline 3 (1mmol) and CSA (10 mol %) in ethanol (2mL) and the
reaction mixture was stirred at 60 C. The progress of reaction was monitored using
TLC. The reaction mixture was quenched with crushed ice and extracted with ethyl
acetate (2 15mL). The organic extract was washed with brine solution (2 15mL)
and dried over anhydrous sodium sulfate, then filtered. The solvent was evaporated
under reduced pressure to afford the corresponding crude compounds. The obtained
crude compounds were recrystallized from ethanol (Table 4).
Representative Compound Data
9,10-bis(4-Chlorophenyl)-3,4,6,7-tetrahydro-3,3,6,6-tetramethyl-4-chlorophenylacridine-
1,8(2H, 5H, 9H, 10H)-dione (4a): Off white solid; mp. 303–305 C. 1H NMR
(400MHz, CDCl3, ppm): d 0.74 (s, 6H), 0.89 (s, 6H), 1.95–2.14 (m, 8H), 5.15 (s, 1H),
7.08–7.15 (m, 5H), 7.20 (s, 1H), 7.46–7.50 (d, 2H). IR (cm1) 2950, 1680, 1577, 1491,
650. MS: 492.14 (Mþ-1).
9-(4-Chlorophenyl)-3,4,6,7-tetrahydro-3,3,6,6-tetramethyl-10-p-tolylacridine-1,8(2H,
5H, 9H, 10H-dione (4b): Off white solid; mp. 273–275 C. 1H NMR (400MHz, CDCl3,
ppm): d 0.8. (s, 6H), 0.94 (s, 6H), 1.87 (s, 1H), 2.03–2.17 (m, 7H), 2.49 (s, 3H), 5.23
(s, 1H), 7.06–7.10 (d, 2H), 7.18–7.23 (m, 2H), 7.33–7.39 (m, 4H). IR (cm1) 2958,
1639, 1574, 1360, 1221, 840; MS: 472.20 (Mþ-1).
9-(4-Chlorophenyl)-3,4,6,7-tetrahydro-3,3,6,6-tetramethyl-10-m-tolylacridine-1,8(2H,
5H, 9H, 10H)-dione (4c): Yellow solid; mp. 242–245 C. 1H NMR (400MHz, CDCl3,
ppm): d 0.73 (s, 6H), 0.88 (s, 6H), 1.79 (s, 1H), 1.96–1.99 (m, 2H), 2.05–2.18 (m, 5H),
2.41 (s, 3H) 5.16 (s, 1H), 6.92–6.95 (m, 1H), 7.12–7.19 (m, 3H), 7.25–7.37 (m, 4H);
MS: 472.20 (Mþ-1).
3,4,6,7-Tetrahydro-3,3,6,6-tetramethyl-9-(4-nitrophenyl)-10-phenylacridine-1,8(2H,
5H, 9H, 10H)-dione (4k): Faint yellow solid; mp. 278–280 C. 1H NMR (400MHz,
CDCl3, ppm): d 0.79 (s, 6H), 0.96–0.99 (s, 6H), 2.05–2.33 (m, 8H), 5.34 (s, 1H),
7.35–7.39 (d, 2H), 7.50 (d, 1H), 7.58–7.62 (d, 2H), 8.05–8.15 (m, 3H); MS: 469.28
(Mþ-1).
Acknowledgments
We thank the Council of Scientific and Industrial Research, New Delhi (110012), for
financial support under a Junior Research Fellowship. We are thankful to the
Principal, Deogiri College, Aurangabad, India, for providing laboratory facilities and
the permission to use the Central Research Laboratories facility.
4 Pawar et al.
References
1. M. Alvala, S. Bhatnaga, A. Ravi, V. U. Jeankumar, T. H. Manjashetty, P. Yogeswari, and D.
Sriram, Bioorg. Med. Chem. Lett., 22, 3256 (2012).
2. A. F. Choksey, S.M. Sirsat, and D.J. Jussawalla Indian J. Exp Biol., 15, 601 (1977).
3. V. Marti-Centelles, M. I. Burgete, F. Galindo, M. A. Izquierdo, D. K. Kumar, A. J. P.
White, S. V. Luis, and R. Vilar, J. Org. Chem., 77, 490 (2012).
4. A. K. Ghosh, A. Samanta, and P. Bandyopadhyay, J. Phys. Chem., 115, 1823 (2011).
5. R.P. Carlos, J.M. Eugenio, J.G. Juan, B. Gerald, M.T. Martın-Romero, and C. Luis,
Langmuir, 27, 14888 (2011).
6. Y. Moriyama, T. Takano, and S. Ohkuma J. Biochemistry, 92, 1333 (1982).
7. M. Mohammadi-Khanaposhtani, M. Shabani, M. Faizi, I. Aghaei, R. Jahani, Z. Sharafi, Z.N.
Shamsaei, M. Mahdavi, T. Akbarzadeh, S. Emami, A. Shafiee, and A. Foroumadi, Eur. J.
Med. Chem., 112, 91 (2016).
8. S. M. Sondhi, G. Bhattacharjee, R. K. Jameel, R.Shukla, R. Raghubir, O. Lozach, and L.
Meijer Central Eur. J. Chem. 2, 1 (2004).
9. T. Kerenyi, R. Lehmann, B. Voss, and H. Jellinek, Exp. Mol. Pathol., 54, 230 (1991).
10. Y. L. Chen, C. M. Lu, I. L. Chen, L. T. Tsao, and J. P. Wang, J. Med. Chem., 45, 4689
(2002).
11. H. Koshima, K. Ding, Y. Chisaka, and T. Matsuura, J. Am. Chem. Soc., 118, 12059 (1996).
12. M. K. Gatasheh, S. Kannan, K. Hemalatha, and N.I. Karbala, Int. J. Modern Sci., 3, 272
(2017).
13. F. Ayme and V. Calienes Open Med. Chem. J., 5, 11 (2011).
14. J. M. Rolland, G. R. Ferrier, R. C. Nairn, and M. N. Cauchi, J. Immunol. Methods, 12, 347
(1976).
15. H. D. Preisler, A. Raza, V. Gopal, S. D. Banavali, J. Bokhari, and L. B. Leuk, Lymphoma
13, 61 (1994).
16. H. W. Tyrer, J. F. Golden, M. H. Vansickel, C. K. Echols, J. K. Frost, S. S. West, N. J.
Pressman, C. D. Albright, L. A. Adams, and G. W. Gill, J. Histochem Cytochem., 27, 552
(1979).
17. C. Scholtissek and H. Becht Nucleic Acids & Protein Synthesis, 123, 585 (1966).
18. H. Alinezhad, M. Tajbakhsh, M. Norouzi, S. Baghery, and J. Rakhtshah, J. Chem. Sci., 125,
1517 (2013).
19. G. M. Ziarani, S. Mousavi, M. Rahimifard, and A. Badiei, J. Mex. Chem. Soc., 58, 168
(2014).
20. M. Faisal, S. Shahid, S. A. Ghumro, A. Saeed, F.A. Larik, and Z. Shaheen, Synth. Commun.,
48, 462 (2018).
21. H.A. Soliman, A.Y. Mubarak, A. El-Mekabati, and S.S. Elmorsy, Chem. Sci. Trans., 3, 819
(2014).
22. H. Alinezhad and S.M. Tavakkoli, The Scientific World J., Article ID 575636 (2013).
23. K.B. Ramesh and M.A. Pasha, Bioorg. Med. Chem. Lett., 24, 3907 (2014).
Acridine Derivatives 5
24. F. Rashedian, D. Saberi, and K. Niknam J. Chin. Chem. Soc., 57, 998 (2010).
25. R. Ghorbani-Vagheia and S. M. Malaekehpoor, J. Iran. Chem. Soc., 7, 957 (2010).
26. G-F. Han, R-H. Wang, W-T Zhang, Y-Y. Zhao, Z. Xing, and W. Dai, Syn. Comm., 39, 2492
(2009).
27. J. J. Xia and K. H. Zhang, Molecules, 17, 5339 (2012).
28. X.-S. Wang, M.-M. Zhang, Z.-S. Zeng, D.-Q. Shi, S.-J. Tu, X.-Y. Wei and Z.-M. Zong,
Arkivoc, ii, 117 (2006).
6 Pawar et al.
